-
Something wrong with this record ?
The pathophysiology of endothelial function in pregnancy and the usefulness of endothelial markers
Ludek Slavik, Jana Prochazkova, Martin Prochazka, Ondrej Simetka, Antonin Hlusi, Jana Ulehlova
Language English Country Czech Republic
Document type Research Support, Non-U.S. Gov't
Grant support
NS10319
MZ0
CEP Register
Digital library NLK
Full text - Article
Source
NLK
Directory of Open Access Journals
from 2001
Free Medical Journals
from 1998
Medline Complete (EBSCOhost)
from 2007-06-01
ROAD: Directory of Open Access Scholarly Resources
from 2001
- MeSH
- Biomarkers analysis MeSH
- Endothelium, Vascular physiology physiopathology MeSH
- Extracellular Matrix metabolism MeSH
- Blood Coagulation Factors metabolism MeSH
- Pregnancy Complications physiopathology MeSH
- Humans MeSH
- Matrix Metalloproteinases metabolism MeSH
- Pregnancy physiology MeSH
- Tissue Inhibitor of Metalloproteinases metabolism MeSH
- Check Tag
- Humans MeSH
- Pregnancy physiology MeSH
- Female MeSH
- Publication type
- Research Support, Non-U.S. Gov't MeSH
Aim. The aim of this study was to assess coagulation markers of endothelial damage and examine new markers of endothelial activation such as matrix metalloproteinases (MMPs) in a group of healthy pregnant women. Matrix metalloproteinase (MMP)-2, in particular, plays a major role in the degradation of the extracellular matrix confirming its essential function in both the survival (angiogenesis) and death of endothelial cells. Detection of specific coagulation factors, mainly released from the vascular endothelium such as vWF, sTM (soluble thrombomodulin) and ePCR (endothelial protein C receptor) and factors dependent on endothelial activation such as t-PA and PAI-1, could provide information on possible endothelial dysfunction and help differentiate pregnant patients with an altered thrombotic state. Methods. Healthy pregnant women underwent complete assessment for endothelial damage (as vWF, vWF activity, sTM, ePCR, EMP, MMP-2, MMP-9 and TIMP-2) using the ELISA and other methods. Results and Conclusions. The results show that endothelial activation during pregnancy is different from that in other pathological conditions involving endothelial damage and typically characterized by higher levels of both coagulation endothelial markers and MMPs. In pregnancy, changes in extracellular matrix composition and matrix metalloproteinase activity also occur and promote vascular remodeling but, only in the uterus. Predisposing risk factors for epithelial dysfunction, and vascular mediators associated with vascular remodeling must be assessed from concentrations in whole blood. The levels of MMPs are not increased in the circulation and the local situation in the uterus cannot be monitored this way. However, MMP-2 processes and modulates the functions of many other vasoactive and pro-inflammatory molecules including adrenomedullin, big endothelin-1, calcitonin gene-related peptide, CCL7/MCP-3, CXCL12/SDF-1, galectin-3, IGFBP-3, IL-1 Beta, S100A8, and S100A9. These molecules represent new potential molecular markers of endothelial damage during pregnancy.
Department of Hemato oncology University Hospital Olomouc
Department of Obsterics and Gynecology University Hospital Olomouc
Department of Obsterics and Gynecology University Hospital Ostrava
References provided by Crossref.org
Obsahuje 1 tabulku
Bibliography, etc.Literatura
- 000
- 00000naa a2200000 a 4500
- 001
- bmc12007343
- 003
- CZ-PrNML
- 005
- 20140910110901.0
- 007
- ta
- 008
- 120309s2011 xr f 000 0eng||
- 009
- AR
- 024 7_
- $a 10.5507/bp.2011.031 $2 doi
- 040 __
- $a ABA008 $d ABA008 $e AACR2 $b cze
- 041 0_
- $a eng
- 044 __
- $a xr
- 100 1_
- $a Slavík, Luděk $7 xx0081908 $u Department of Hemato-oncology, University Hospital Olomouc
- 245 14
- $a The pathophysiology of endothelial function in pregnancy and the usefulness of endothelial markers / $c Ludek Slavik, Jana Prochazkova, Martin Prochazka, Ondrej Simetka, Antonin Hlusi, Jana Ulehlova
- 500 __
- $a Obsahuje 1 tabulku
- 504 __
- $a Literatura $b 47
- 520 9_
- $a Aim. The aim of this study was to assess coagulation markers of endothelial damage and examine new markers of endothelial activation such as matrix metalloproteinases (MMPs) in a group of healthy pregnant women. Matrix metalloproteinase (MMP)-2, in particular, plays a major role in the degradation of the extracellular matrix confirming its essential function in both the survival (angiogenesis) and death of endothelial cells. Detection of specific coagulation factors, mainly released from the vascular endothelium such as vWF, sTM (soluble thrombomodulin) and ePCR (endothelial protein C receptor) and factors dependent on endothelial activation such as t-PA and PAI-1, could provide information on possible endothelial dysfunction and help differentiate pregnant patients with an altered thrombotic state. Methods. Healthy pregnant women underwent complete assessment for endothelial damage (as vWF, vWF activity, sTM, ePCR, EMP, MMP-2, MMP-9 and TIMP-2) using the ELISA and other methods. Results and Conclusions. The results show that endothelial activation during pregnancy is different from that in other pathological conditions involving endothelial damage and typically characterized by higher levels of both coagulation endothelial markers and MMPs. In pregnancy, changes in extracellular matrix composition and matrix metalloproteinase activity also occur and promote vascular remodeling but, only in the uterus. Predisposing risk factors for epithelial dysfunction, and vascular mediators associated with vascular remodeling must be assessed from concentrations in whole blood. The levels of MMPs are not increased in the circulation and the local situation in the uterus cannot be monitored this way. However, MMP-2 processes and modulates the functions of many other vasoactive and pro-inflammatory molecules including adrenomedullin, big endothelin-1, calcitonin gene-related peptide, CCL7/MCP-3, CXCL12/SDF-1, galectin-3, IGFBP-3, IL-1 Beta, S100A8, and S100A9. These molecules represent new potential molecular markers of endothelial damage during pregnancy.
- 650 _2
- $a biologické markery $x analýza $7 D015415
- 650 _2
- $a koagulační faktory $x metabolismus $7 D001779
- 650 _2
- $a cévní endotel $x fyziologie $x patofyziologie $7 D004730
- 650 _2
- $a extracelulární matrix $x metabolismus $7 D005109
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a matrixové metaloproteinasy $x metabolismus $7 D020782
- 650 _2
- $a těhotenství $x fyziologie $7 D011247
- 650 _2
- $a komplikace těhotenství $x patofyziologie $7 D011248
- 650 _2
- $a tkáňové inhibitory metaloproteinas $x metabolismus $7 D019714
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Procházková, Jana $7 xx0067433 $u Department of Hemato-oncology, University Hospital Olomouc
- 700 1_
- $a Procházka, Martin, $7 xx0019288 $u Department of Obsterics and Gynecology, University Hospital Olomouc $d 1970-
- 700 1_
- $a Šimetka, Ondřej, $7 xx0096494 $u Department of Obsterics and Gynecology, University Hospital Ostrava $d 1970-
- 700 1_
- $a Hluší, Antonín $7 xx0074065 $u Department of Hemato-oncology, University Hospital Olomouc
- 700 1_
- $a Úlehlová, Jana $7 xx0117725 $u Department of Hemato-oncology, University Hospital Olomouc
- 773 0_
- $t Biomedical papers $x 1213-8118 $g Roč. 155, č. 4 (2011), s. 333-337 $w MED00012606
- 910 __
- $a ABA008 $b A 1502 $c 958 $y 2 $z 0
- 990 __
- $a 20120309115236 $b ABA008
- 991 __
- $a 20140910111303 $b ABA008
- 999 __
- $a ok $b bmc $g 900475 $s 764207
- BAS __
- $a 3
- BMC __
- $a 2011 $b 155 $c 4 $d 333-337 $i 1213-8118 $m Biomedical papers of the Medical Faculty of the University Palacký, Olomouc Czech Republic $n Biomed. Pap. Fac. Med. Palacký Univ. Olomouc Czech Repub. (Print) $x MED00012606
- GRA __
- $a NS10319 $p MZ0
- LZP __
- $a 2012-11/dkme